University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)
University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)
批准号:
10366062
负责人:
Bruce R Blazar
金额:
$577.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-03-30 至 2023-11-17
关键词:
AdministratorAdultAgreementAreaAwardBiometryBudgetsBusinessesCalendarChildhoodClinicClinicalClinical ResearchClinical SciencesClinical TrialsClinics and HospitalsCollectionCommunicationCommunitiesCommunity HealthCommunity Health ServicesCommunity OutreachCompetenceComplexConsentConsent FormsConsultCountyCounty HospitalsDataDevelopmentDevelopment PlansDevicesDiverse WorkforceDropsEducationEnrollmentEnsureEthicsFeedbackFosteringFunding OpportunitiesHealthHealth SciencesHealth ServicesHealth systemHospitalsHousingHumanIncentivesIndustryInformation ManagementInfrastructureInstitutesInstitutional Review BoardsLaboratory ResearchLatinoLearningLinkLocationLogicLongevityMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasuresMediationMedicalMedical centerMethodsMidwestern United StatesMinnesotaMissionModelingNational Center for Advancing Translational SciencesNative AmericansOperative Surgical ProceduresParticipantPartner in relationshipPathway interactionsPatientsPediatric HospitalsPopulationPopulation HeterogeneityPriceProcessProtocols documentationPublic HealthReduce health disparitiesResearchResearch PersonnelResearch SupportRewardsScienceServicesSiteSystemTechnologyTrainingTraining ProgramsTranslational ResearchTranslationsUnderrepresented PopulationsUnderserved PopulationUniversitiesVisionVisitbasebiomedical informaticscare outcomescareer developmentcohortcommercializationcommunity engagementcommunity involvementcommunity partnershipdata accessdata sharingdesignethnic minorityexperiencehealth care deliveryhealth outcome disparityimprovedindexingindustry partnerinformatics toolinnovationmagnetic fieldmeetingsmembermultidisciplinarynext generationparallel processingprogramsquality assuranceracial and ethnicrecruitresponsible research conductsafety netskillsspectroscopic imagingtertiary caretooluser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Contact PD/PI: Blazar, Bruce
A. Overall: Abstract. The University of Minnesota's Clinical and Translational Science Institute's (UMN
CTSI) vision is a world where impactful discoveries leading to the betterment of human health occur by
bringing together Academic Health Center (AHC) research with community outreach and industry
partnership. Our mission is to create a nationally-recognized, shareable model of complex translational team
science driven and enabled by integration and alignment of clinical and translational science (CTS) research
with education, data access, community needs, and industry efforts. In the past 6 years, CTSI 1) Developed
comprehensive programs for workforce training and fostering career development for the next generation of
CTS research investigators; 2) Created Community Engagement to Advance Research and Community
Health (CEARCH) to support stakeholder community contributions to CTS research and to tackle health
outcome disparity challenges in Somali, Latino, Native American, Hmong, and other populations; 3)
Leveraged UMN research strengths and MN's vibrant biomedical industry to advance multiple projects along
the commercialization pathway; and 4) Expanded its patient base from the UMN tertiary care adult and
pediatric hospitals to hub partners consisting of a VA hospital, a community-based 7-hospital system, and a
safety-net county hospital with 65% racial/ethnic minorities linked with i2b2/SHRINE for cohort identification.
CTSI formed an unprecedented partnership with Mayo CTSA to provide statewide coverage in CTS
research and education and is a founding member of the Midwest Area Research Consortium for Health, the
Accrual to Clinical Trials federated cohort discovery consortium, and PCORnet Greater Plains Collaborative.
To accelerate and improve CTS research and education and make lasting impacts on healthcare outcomes,
we will pursue the following aims: 1. Train an outstanding multidisciplinary, diverse workforce across the
CTS research spectrum skilled in and rewarded for team science using existing and new educational
offerings; 2. Streamline methods and processes to increase local and national CTSI hub research capacity
in a new Clinics and Surgery Center learning health system with CTSI-led research process design, CTSI's
new StudyFinder tool, user-friendly IRB-approved consent form for clinical and laboratory research, bioinfor-
matics tools, biospecimen collection, and a transformative Clinical Research Support Center for one-stop,
single location, parallel processing of needed approvals; 3. Engage communities and stakeholders through
CEARCH to improve translation and healthcare delivery across the lifespan and to a diverse population; and
4. Add unique contributions to the CTSA network by the Office of Discovery and Translation , Pediatric
Device Innovation Consortium, and high and ultrahigh magnetic resonance imaging and spectroscopy
applications and training. Impact. Connected to and driven by its vision and mission, CTSI will provide
infrastructure and services for conducting innovative, high-impact and efficient, high-quality CTS research.
Project Summary/Abstract Page 391
Contact PD/PI: Blazar, Bruce
期刊论文(608)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jaad.2020.08.047
发表时间:
2021-11
期刊:
Journal of the American Academy of Dermatology
影响因子:
13.8
作者:
[Ruggiero JL, Dodds M, Freese R, Polcari IC, Maguiness S, Hook KP, Boull C]
通讯作者:
Boull C
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?
成本效益分析能否为基因型引导的阿司匹林用于预防原发性结直肠癌的使用吗?
DOI:
10.1158/1055-9965.epi-19-1580
发表时间:
2021-06
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
[Biltaji E, Walker B, Au TH, Rivers Z, Ose J, Li CI, Brixner DI, Stenehjem DD, Ulrich CM]
通讯作者:
Ulrich CM
Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis.
患有囊性纤维化的成年人超重和肥胖相关的患病率和因素:单中心分析。
DOI:
10.1016/j.jcf.2019.10.004
发表时间:
2020-01
期刊:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
影响因子:
--
作者:
[Harindhanavudhi T, Wang Q, Dunitz J, Moran A, Moheet A]
通讯作者:
Moheet A
DOI:
10.1016/j.jand.2021.07.002
发表时间:
2022-01
期刊:
Journal of the Academy of Nutrition and Dietetics
影响因子:
4.8
作者:
[Horning ML, Friend S, Lee J, Flattum C, Fulkerson JA]
通讯作者:
Fulkerson JA
DOI:
10.1017/s1368980023001520
发表时间:
2023-11
期刊:
PUBLIC HEALTH NUTRITION
影响因子:
3.2
作者:
[Caspi, Caitlin E., Gombi-Vaca, Maria Fernanda, Wolfson, Julian, Harnack, Lisa J., De Marco, Molly, Pratt, Rebekah, Durfee, Thomas, Myers Jr, Samuel L.]
通讯作者:
Myers Jr, Samuel L.
共 427 条
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
-
批准号:10763967
-
项目类别:
-
资助金额:$772.72万
-
财政年份:2023
-
负责人:Bruce R Blazar
-
依托单位:
In Vivo Prevention of Murine GVHD
-
批准号:10362877
-
项目类别:
-
资助金额:$60.35万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
Metabolomics of cGVHD
-
批准号:10698171
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
In Vivo Prevention of Murine GVHD
-
批准号:10610863
-
项目类别:
-
资助金额:$58.97万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
Metabolomics of cGVHD
-
批准号:10493800
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
-
批准号:10560605
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2021
-
负责人:Bruce R Blazar
-
依托单位:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
-
批准号:10092348
-
项目类别:
-
资助金额:$67.52万
-
财政年份:2021
-
负责人:Bruce R Blazar
-
依托单位:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
-
批准号:10348683
-
项目类别:
-
资助金额:$66.24万
-
财政年份:2021
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:10305635
-
项目类别:
-
资助金额:$6.75万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:10656502
-
项目类别:
-
资助金额:$81.18万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:9888096
-
项目类别:
-
资助金额:$84.95万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:10532723
-
项目类别:
-
资助金额:$75.14万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)
-
批准号:9901640
-
项目类别:
-
资助金额:$697.02万
-
财政年份:2018
-
负责人:Bruce R Blazar
-
依托单位:
Preclinical Drug Approaches to Chronic GVHD Prevention and Treatment
-
批准号:8881478
-
项目类别:
-
资助金额:$20.95万
-
财政年份:2015
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:8837683
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Mechanisms, Prevention and Treatment of Chronic GVHD
-
批准号:8746996
-
项目类别:
-
资助金额:$62.81万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:10616775
-
项目类别:
-
资助金额:$69.68万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:8690244
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:10452167
-
项目类别:
-
资助金额:$72.25万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:9905424
-
项目类别:
-
资助金额:$54.94万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
海外基金